Company intelligence / Profile preview

Daiichi Yakuhin Sangyo

Chuo-ku, Tokyo, Japan
Ownership
Private
Employees
~130
Development stage
Other
01

Overview

Daiichi Yakuhin Sangyo is a Japanese pharmaceutical company specializing in the manufacture and distribution of over-the-counter (OTC) drugs, reagents, and industrial chemicals. Established in 1947 and headquartered in Tokyo, the company operates as a subsidiary of Alfresa Holdings Corporation. Its product portfolio includes nutritional supplements, gastrointestinal treatments, and a wide array of chemical reagents used in clinical and industrial laboratories. Beyond product sales, the company provides contract manufacturing (CMO) services, leveraging its GMP-compliant facilities to produce various pharmaceutical dosage forms. As part of the Alfresa Group, it contributes to a comprehensive healthcare supply chain within the Japanese market.

Therapeutic areas
Infectious DiseasesMetabolic DisordersGastroenterology
Modalities
Small molecule
Industry
Pharma
02

Drug pipeline

1 asset

lecithinized iodine

Unknown
03

Partnerships

Alfresa Holdings

Beyond the preview

Go deeper on Daiichi Yakuhin Sangyo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daiichi Yakuhin Sangyo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call